PreveCeutical Medical Inc.
PREV
CNSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.86M | -1.22M | -857.90K | -996.30K | -928.80K |
| Total Depreciation and Amortization | 8.80K | 7.70K | 7.40K | 7.40K | 7.30K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 758.00K | 376.30K | 287.20K | 269.70K | 267.20K |
| Change in Net Operating Assets | 484.00K | 490.30K | 251.60K | 427.30K | 408.20K |
| Cash from Operations | -606.90K | -341.00K | -311.60K | -291.80K | -246.00K |
| Capital Expenditure | -2.70K | -700.00 | -1.30K | -800.00 | -700.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -39.70K | -40.00K | -- | -- | -- |
| Cash from Investing | -42.40K | -40.70K | -1.30K | -800.00 | -700.00 |
| Total Debt Issued | 106.00K | 320.90K | 322.40K | 276.40K | 302.20K |
| Total Debt Repaid | -69.80K | -74.50K | -74.50K | -73.00K | -72.00K |
| Issuance of Common Stock | 872.40K | 289.70K | 239.70K | 195.80K | 105.80K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 654.00K | 386.30K | 355.20K | 292.80K | 247.00K |
| Foreign Exchange rate Adjustments | -700.00 | -1.70K | -1.10K | -1.20K | -2.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.80K | 2.80K | 41.20K | -1.10K | -1.70K |